Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

Credit: Reese Pharmaceutical. ColoTest is designed to detect blood in stool, which may be an early indication for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis or polyps.

The question posed is an interesting one, and is commonly encountered in clinical practice. The issue revolves around a number of factors, and some clinical data are needed that are not presented. One ...

A new study conducted in the UK and published in Gut found blood detected in stool is associated with an increased risk of death from a wide range of causes, not just colorectal cancer. The ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Abnormal results ...

Squamous Cell Carcinoma of the Anus Incidence, Mortality, and Survival Among the General Population and Persons Living With HIV in Puerto Rico, 2000-2016 The median age of participants was 61 years ...

Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...

To the Editor: Mandel and associates (Nov. 30 issue) 1 show that either annual or biennial fecal occult-blood testing significantly reduces the incidence of colorectal cancer. Their findings were ...

Socio-economic, environmental factors and general practitioner (GP) involvement may influence adherence to repeat faecal occult blood testing (FOBT) of organised colorectal cancer (CRC) screening. The ...

Please provide your email address to receive an email when new articles are posted on . The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests ...

Enterix Inc announced its U.S. launch of !nSure FOBT, a new immunochemical fecal occult blood test, at Digestive Disease Week ("DDW") in Atlanta, Georgia. !nSure is an immunochemical fecal occult ...